Clinical Trials Sponsored by FALCK Foundation
Total 15749 results
-
Sally FalkCompleted
-
Sally FalkUnknownLung Cancer | Prostate CancerUnited Kingdom
-
University of AarhusFalck DanmarkTerminatedMyocardial InfarctionDenmark
-
Bayside HealthMonash University; Baker Heart and Diabetes Institute; Ambulance Victoria; FALCK...UnknownCoronary Artery Disease | Acute Myocardial InfarctionAustralia
-
Sophiahemmet UniversityFalck Ambulance A/S; CrashCourse ABRecruitingTraining | Triage | Learning | Mass Casualty IncidentSweden
-
Sally FalkUniversity of ManchesterUnknown
-
Fondazione Don Carlo Gnocchi OnlusFondazione Ico FalckNot yet recruitingMultiple Sclerosis | Parkinson Disease | Post-stroke
-
Dr. Falk Pharma GmbHRecruiting
-
Dr. Falk Pharma GmbHRecruiting
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompletedIncomplete Microscopic ColitisGermany, Sweden
-
Dr. Falk Pharma GmbHTerminatedPrimary Biliary CirrhosisFrance, Germany
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHTerminatedRadiation ProctitisGermany
-
Kyle FlackCompleted
-
Dr. Falk Pharma GmbHRecruiting
-
Dr. Falk Pharma GmbHCompletedEosinophilic EsophagitisGermany
-
Dr. Falk Pharma GmbHCompletedTraveler's DiarrheaEcuador, Guatemala, India
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHTerminatedDiverticulitisUnited States
-
Dr. Falk Pharma GmbHCompletedEosinophilic EsophagitisGermany
-
Dr. Falk Pharma GmbHCompletedActive Ulcerative ColitisGermany
-
Dr. Falk Pharma GmbHCompletedColonic DiverticulosisGermany
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompletedCrohn´s DiseaseGermany
-
Dr. Falk Pharma GmbHRecruiting
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompletedPrimary Biliary CirrhosisGermany
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompletedUncomplicated DiverticulitisGermany
-
Dr. Falk Pharma GmbHTerminatedDiverticulitisGermany
-
Dr. Falk Pharma GmbHTerminatedUlcerative ColitisGermany
-
Dr. Falk Pharma GmbHCompletedPrimary Sclerosing CholangitisAustria, Germany, Norway
-
Dr. Falk Pharma GmbHCompletedOral Chronic Graft vs Host DiseaseGermany, Israel
-
Dr. Falk Pharma GmbHCompletedEosinophilic EsophagitisGermany
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompletedCollagenous ColitisGermany
-
Dr. Falk Pharma GmbHCompletedColitis, UlcerativeGermany
-
Dr. Falk Pharma GmbHCompletedPreventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus MesalazineCrohn's DiseaseAustria, Germany
-
Dr. Falk Pharma GmbHCompletedRecurrence | Colitis, UlcerativeGermany
-
Rafa LaboratoriesDr. Falk Pharma GmbHCompleted
-
University of AarhusThe Hospital for Sick Children; Royal Brompton & Harefield NHS Foundation Trust and other collaboratorsCompleted
-
Technische Universität DresdenDr. Falk Pharma GmbHCompletedLeukemia | Graft-Versus-Host DiseaseGermany
-
Technische Universität DresdenDr. Falk Pharma GmbHCompleted
-
Dr Falk Mueller-RiemenschneiderUnknown
-
Sublimity Therapeutics Holdco LimitedDr. Falk Pharma GmbHTerminatedColitis, UlcerativeUnited States, United Kingdom, Serbia, Canada, Russian Federation, Poland, Israel, Romania, Ireland, Spain, Hungary, Ukraine, Belarus, Italy, Bulgaria, France, Germany
-
Russian Academy of Medical SciencesDr. Falk Pharma GmbHCompletedGastroesophageal Reflux DiseaseRussian Federation